Nimitz Health
Your guide to health policy in Washington, DC
Congress wrestles over a health-care rider as 100% drug duties near, putting costs, coverage, and supply chains on edge.
Proposals to align FDA and CMS decisions, speed evidence development, and reduce multi-year access bottlenecks.
Senate Aging Committee talks China/India dependencies, shortage math, and real market levers.
Witnesses described political sign-offs on science, late or missing data, and a vaccine panel reset that may reshape childhood schedules.
HHS cuts advance, drug-ad risks go bold, states protect school vaccines. Here are the health policy updates you need going into the week.
Lawmakers sparred over nutrition, vaccine messaging, and HHS and USDA leadership in a contentious hearing on children's health.
Senate HSGAC has sharp clashes over data access, study design, and the civic climate around public health.
Lawmakers press PBM changes and ACA relief as GOP rifts over RFK Jr. deepen. Here is what you need to know going into the week.
ACIP firings, booster access, and evidence standards dominate as lawmakers and HHS trade shots over vaccine policy and CDC credibility.
Congress talks about earlier diagnosis, less paperwork, and keeping physicians in charge—not replacing them.
FY26 funding sprint, CDC shake-up, mRNA retrenchment, and what Congress + the White House plan before year-end.
Senate version rejects steep CDC cuts, sustains disease prevention programs, and invests in preparedness measures to respond to future health threats.
